Addressing Evidence Development Requirements for Improved Market Access of Orphan Disease Therapies, Upcoming Webinar Hosted by Xtalks

Share Article

Globally, there is increasing demand for an evidence-based approach toward pricing and reimbursement for drug and gene therapies used to treat orphan diseases. However, Health Technology Assessments (HTAs) face complex submissions with limited data, which can set back their progress in drug development. In this free webinar, the featured speakers will discuss current challenges with data capture and innovative approaches to filling important evidence gaps.

Xtalks Life Science Webinars

With limited data, HTAs have had to make assumptions to inform cost-effectiveness analyses, and companies can suffer if they’re unable to provide evidence-based arguments for their own assumptions, even in rare diseases.

On Wednesday, October 9, 2019 at 11am EDT (4pm BST/UK), join Thomas F. Goss, PharmD, Senior Vice President of Boston Healthcare and Tony Bower, PhD, President of Bower Research Group LLC in a live webinar where they will discuss the challenges of identifying relevant data sources to document disease burden. This is becoming increasingly important for development-stage pharmaceutical and biotechnology companies that are investigating rare diseases.

In this free webinar, attendees will learn about current submission standards for Health Technology Assessments (HTAs). With limited data, HTAs have had to make assumptions to inform cost-effectiveness analyses, and companies can suffer if they’re unable to provide evidence-based arguments for their own assumptions, even in rare diseases.

Topics to be discussed include:

  • Assessments of disease burden:
  • Disease impact on quality of life
  • Costs to the healthcare system
  • Evidence to support market access and reimbursement decisions
  • Strengths & limitations of available methods of data capture
  • Key challenges & potential solutions in identifying relevant data sources

For more information or to register for this event, visit Addressing Evidence Development Requirements for Improved Market Access of Orphan Disease Therapies.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Xtalks Life Science Webinars
Xtalks
1 (416) 977-6555
Email >
Visit website